Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes-Reference-Cited by-同舟云学术

Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes

Published:2014-12-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vrinten Charlotte¹,van der Zwaag Angeli M¹,Weinreich Stephanie S¹,Scholten Rob JPM²,Verschuuren Jan JGM³

Affiliation:

1. VU University Medical Center; Community Genetics Section, Clinical Genetics; BS7, D450 PO Box 7057 Amsterdam Netherlands 1007 MB

2. Julius Center for Health Sciences and Primary Care / University Medical Center Utrecht; Dutch Cochrane Centre; Room Str. 6.126 P.O. Box 85500 Utrecht Netherlands 3508 GA

3. Leiden University Medical Center; Department of Neurology; PO Box 9600 Leiden Netherlands 2300 RC

Publisher

Wiley

Subject

Pharmacology (medical)

Reference135 articles.

1. Treatment of congenital myasthenia with ephedrine: a case report;Edvardson;European Journal of Paediatric Neurology,2007

2. Abicht A Lochmüller H Congenital Myasthenic Syndromes GeneReviews at Gene Tests: Medical Genetics Information Resource (database online) Seattle University of Washington. Available at www.ncbi.nlm.nih.gov/books/NBK1168/

3. Congenital myasthenia as a cause of respiratory failure in two infants and a toddler: case reports;Adamovičová;Ceska a Slovenska Neurologie a Neurochirurgie,2012

4. Variable phenotypes associated with mutations in DOK7;Anderson;Muscle & Nerve,2008

5. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine;Banwell;Neuromuscular Disorders,2004

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance of Early Treatment of Inherited Neuromuscular Conditions;Journal of Neuromuscular Diseases;2024-03-05

2. Myasthenia gravis—Pathophysiology, diagnosis, and treatment;Handbook of Clinical Neurology;2024

3. Pharmacological Treatments for Congenital Myasthenic Syndromes Caused by COLQ Mutations;Current Neuropharmacology;2023-07

4. Current Treatment of Myasthenia Gravis;Journal of Clinical Medicine;2022-03-14

5. Novel LG1 Mutations in Agrin Causing Congenital Myasthenia Syndrome;Internal Medicine;2021